Late breaking clinical trials in interventional cardiovascular medicine to be presented at TCT 2010
Wed, 08 Sep 2010 04:52:42 -0700
Clinical trials in a variety of areas within interventional cardiovascular medicine that will be presented at TCT 2010 will directly affect the way that people with cardiovascular disease are treated. Breakthroughs in science and medical research, presented exclusively at TCT, will lead to new treatments that are minimally invasive and involve shorter recovery times. Among the topics being ...
Read More...
Fibrocell Science, Inc. Names Biotechnology and Genetic Research Expert Stefan Gruenwald, M.D., Ph.D., to Scientific ...
Tue, 07 Sep 2010 05:00:00 -0700
Fibrocell Science, Inc. , a biotechnology company focused on the development of autologous cell therapies for aesthetic, medical and scientific applications, announced today the appointment of Stefan Gruenwald, M.D., Ph.D., to its scientific advisory board.
Read More...
